https://www.targetedonc.com/view/recent-data-updates-from-prima-and-paola-1-trials-in-ovarian-cancer
0
0
8/11/23 at 9:06pm
Organization
Targetedonc.com
33 words
0
Comments
Key takeaways from recent data updates from the PRIMA and PAOLA-1 trials investigating PARP inhibitors in ovarian cancer.
You are the first to view
Create an account
or login to join the discussion